tweenvest

Asiatic Laboratories Limited (DSE: ASIATICLAB)

Health Care · Pharmaceuticals · BD

Tk107.30

+2.88% today · +117.2% 1Y

Public summary
A free snapshot of Asiatic Laboratories Limited, with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

Asiatic Laboratories Limited (DSE: ASIATICLAB) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $104.89M.

Over the last twelve months the share price has gained 117.2%, trading between 44.20 and 146.90.

Tweenvest scores Asiatic Laboratories Limited across four factors: quality 68/100, value 60/100, growth 1/100, dividend 37/100. Its strongest factor is quality.

ASIATICLAB price history

Nov 23, 2025 · 54.00Weekly closes 46.60 – 143.00Nov 12, 2026 · 107.30

Key figures

Market cap
$104.89M
Revenue (TTM)
$23.69M
P/E
24.72
EPS
2.09
Dividend yield
0.93%
Beta (5Y)
0.52
52-week high
Tk146.90
52-week low
Tk44.20
Avg volume (3M)
—
Shares outstanding
122.39M
Employees
—
Next earnings
—
CompanyMarket capPriceDay
CellBion Co., Ltd.KOSDAQ: A308430$108.06M₩11,180.00-1.41%
Vikram Thermo (India) LimitedBSE: 530477$106.36MRs319.80-0.11%
RaQualia Pharma Inc.TSE: 4579$105.18M¥646.00-3.15%
BGM Group Ltd.NasdaqCM: BGM$105.16M$7.88+2.27%
Journey Medical CorporationNasdaqCM: DERM$104.15M$3.69-5.38%
Organigram Global Inc.TSX: OGI$102.49MCA$1.04-11.86%
Semnur Pharmaceuticals, Inc.OTCPK: SMNR$102.32M$0.47+42.42%
Retension Pharmaceuticals, Inc.NasdaqCM: RTSN$102.23M$12.27+0.16%

Browse every Pharmaceuticals company →